Siqi Ming

990 total citations
35 papers, 645 citations indexed

About

Siqi Ming is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Siqi Ming has authored 35 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 7 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Siqi Ming's work include Immune Cell Function and Interaction (13 papers), Inflammation biomarkers and pathways (7 papers) and Immune Response and Inflammation (7 papers). Siqi Ming is often cited by papers focused on Immune Cell Function and Interaction (13 papers), Inflammation biomarkers and pathways (7 papers) and Immune Response and Inflammation (7 papers). Siqi Ming collaborates with scholars based in China, United States and Canada. Siqi Ming's co-authors include Yongjian Wu, Xi Huang, Minhao Wu, Hong Shan, Guanmin Jiang, Sitang Gong, Xiaomin Cheng, Jiahai Lu, Lantian Tang and Cheng Guo and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Siqi Ming

34 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siqi Ming China 14 266 253 179 70 63 35 645
Kerry L. Hilligan New Zealand 11 411 1.5× 191 0.8× 159 0.9× 56 0.8× 42 0.7× 18 705
Hongfei Zhu China 14 173 0.7× 173 0.7× 58 0.3× 77 1.1× 51 0.8× 21 514
Xialin Du China 14 204 0.8× 224 0.9× 101 0.6× 113 1.6× 107 1.7× 23 497
Daniel Peltier United States 14 232 0.9× 252 1.0× 103 0.6× 64 0.9× 58 0.9× 32 590
Michael Hiltensperger Germany 7 299 1.1× 399 1.6× 134 0.7× 129 1.8× 15 0.2× 9 858
Emeka B. Okeke Canada 11 384 1.4× 184 0.7× 46 0.3× 80 1.1× 31 0.5× 13 620
Kurt B. Pruner United States 3 276 1.0× 107 0.4× 135 0.8× 45 0.6× 25 0.4× 6 503
Ashley M. Hine United States 8 267 1.0× 277 1.1× 91 0.5× 78 1.1× 32 0.5× 14 630
Lixiang Wang China 15 83 0.3× 142 0.6× 72 0.4× 76 1.1× 32 0.5× 58 624
Lyora A. Cohen Israel 7 103 0.4× 175 0.7× 73 0.4× 60 0.9× 38 0.6× 8 762

Countries citing papers authored by Siqi Ming

Since Specialization
Citations

This map shows the geographic impact of Siqi Ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siqi Ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siqi Ming more than expected).

Fields of papers citing papers by Siqi Ming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siqi Ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siqi Ming. The network helps show where Siqi Ming may publish in the future.

Co-authorship network of co-authors of Siqi Ming

This figure shows the co-authorship network connecting the top 25 collaborators of Siqi Ming. A scholar is included among the top collaborators of Siqi Ming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siqi Ming. Siqi Ming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jialiang, Siqi Ming, Yuanhui Zhang, Hongbin Liu, & Na Duan. (2025). Insights on anaerobic co-digestion of carbohydrate and protein at high load: synergy evolution and inhibition transfer mechanism. Chemical Engineering Journal. 518. 164535–164535.
2.
Ming, Siqi, et al.. (2025). The role of TREM2 in sepsis. Reply.. Journal of Clinical Investigation. 135(4). 1 indexed citations
3.
Wang, Qiaohua, et al.. (2024). HSP70 contributes to pathogenesis of fulminant hepatitis induced by coronavirus. International Immunopharmacology. 141. 112963–112963. 1 indexed citations
4.
Ming, Siqi, Xingyu Li, Qiaohua Wang, et al.. (2024). TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis. Journal of Clinical Investigation. 135(1). 10 indexed citations
5.
Zhou, Jinyu, Can Cao, Yiting Liu, et al.. (2024). GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3. Cellular and Molecular Immunology. 21(7). 674–688. 12 indexed citations
6.
Liang, Pingping, Li Ping Wang, Bin Li, et al.. (2024). LncRNA-mRNA co-expression analysis reveals aquaporin-9-promoted neutrophil extracellular trap formation and inflammatory activation in sepsis. International Immunopharmacology. 140. 112916–112916. 4 indexed citations
7.
Ming, Siqi, Yongjian Wu, Jia‐You Wei, et al.. (2023). COVID‐19 Metabolomic‐Guided Amino Acid Therapy Protects from Inflammation and Disease Sequelae. Advanced Biology. 7(8). 4 indexed citations
8.
Wu, Yongjian, Qiaohua Wang, Miao Li, et al.. (2023). SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis. Journal of Clinical Investigation. 133(6). 33 indexed citations
9.
Chen, Kang, Mei Zhang, Zhiying Wang, et al.. (2023). FGL1-LAG3 axis impairs IL-10-Producing regulatory T cells associated with Systemic lupus erythematosus disease activity. Heliyon. 9(10). e20806–e20806. 3 indexed citations
10.
Hu, Shengfeng, Huiting Xu, Yongjian Wu, et al.. (2023). TREM-2 Drives Development of Multiple Sclerosis by Promoting Pathogenic Th17 Polarization. Neuroscience Bulletin. 40(1). 17–34. 6 indexed citations
11.
Cao, Can, Xiaoli Niu, Siqi Ming, et al.. (2022). OX40 enhances T cell immune response to PD-1 blockade therapy in non-small cell lung cancer. International Immunopharmacology. 108. 108813–108813. 11 indexed citations
12.
Wang, Manni, Siqi Ming, Zibin Liang, et al.. (2021). TARM-1 Is Critical for Macrophage Activation and Th1 Response in Mycobacterium tuberculosis Infection. The Journal of Immunology. 207(1). 234–243. 10 indexed citations
13.
Li, Jiaying, Siqi Ming, Ziyan Zhang, et al.. (2021). Tetrahedral DNA nanostructures synergize with MnO2 to enhance antitumor immunity via promoting STING activation and M1 polarization. Acta Pharmaceutica Sinica B. 12(5). 2494–2505. 31 indexed citations
14.
Wu, Yongjian, Xiaomin Cheng, Guanmin Jiang, et al.. (2021). Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. npj Biofilms and Microbiomes. 7(1). 61–61. 139 indexed citations
15.
Zhang, Shun-Xian, Xiaoqin Li, Li Zhu, et al.. (2021). CD163+ macrophages suppress T cell response by producing TGF-β in pediatric colorectal polyps. International Immunopharmacology. 96. 107644–107644. 10 indexed citations
16.
Ming, Siqi, Chunna Li, Hongli Wang, et al.. (2020). CD103 Promotes the Pro-inflammatory Response of Gastric Resident CD4+ T Cell in Helicobacter pylori-Positive Gastritis. Frontiers in Cellular and Infection Microbiology. 10. 436–436. 11 indexed citations
17.
Liu, Jiao, Siqi Ming, Weifeng Song, et al.. (2020). B and T lymphocyte attenuator regulates autophagy in mycobacterial infection via the AKT/mTOR signal pathway. International Immunopharmacology. 91. 107215–107215. 12 indexed citations
18.
Zhang, Mei, Siqi Ming, Sitang Gong, et al.. (2019). Activation-Induced Cell Death of Mucosal-Associated Invariant T Cells Is Amplified by OX40 in Type 2 Diabetic Patients. The Journal of Immunology. 203(10). 2614–2620. 20 indexed citations
19.
Huang, Chunliu, Junjie Shi, Yibin Guo, et al.. (2017). A snoRNA modulates mRNA 3′ end processing and regulates the expression of a subset of mRNAs. Nucleic Acids Research. 45(15). 8647–8660. 77 indexed citations
20.
Yang, Kun, Yongjian Wu, Miao Li, et al.. (2016). Macrophage-mediated inflammatory response decreases mycobacterial survival in mouse MSCs by augmenting NO production. Scientific Reports. 6(1). 27326–27326. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026